Literature DB >> 17375260

Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.

Anna Caroli1, Cristina Testa, Cristina Geroldi, Flavio Nobili, Ugo P Guerra, Matteo Bonetti, Giovanni B Frisoni.   

Abstract

OBJECTIVE: To assess the association of Medial Temporal lobe Atrophy (MTA) and White Matter Hyperintensities (WMHs) with gray matter perfusion in Mild Cognitive Impairment (MCI).
METHODS: 56 MCI patients (age = 69.3 +/- 7.0, 32 females) underwent brain MR scan and (99m)Tc ECD SPECT. We evaluated MTA according to Scheltens' fivepoint scale on T1 MR images, and assessed WMHs using the rating scale for age-related white matter changes on T2-weighted and FLAIR MR images. We divided MCI into age-matched subgroups with high and low MTA and high and low WMHs load. We processed SPECT images with SPM2 following an optimized protocol and performed a voxel-based statistical analysis comparing high vs. low MTA and high vs. low WMHs, setting p-value at 0.001 uncorrected, thresholding cluster extent at 100 voxels, using proportional scaling and entering age and WMHs or MTA respectively as nuisance covariates.
RESULTS: MCI with high compared with low MTA showed hypoperfusion in the left hippocampus and in the left parahippocampal gyrus. MCI with high compared with low WMHs showed a hypoperfusion area in the left insular region and superior temporal gyrus.
CONCLUSIONS: MTA in MCI is associated with hippocampal gray matter hypoperfusion while WMHs is associated with gray matter hypoperfusion in areas of the insula and temporal neocortex. These results confirm that MTA is associated with local functional changes and suggest that WMHs may be associated with remote brain cortical dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17375260     DOI: 10.1007/s00415-006-0498-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry.

Authors:  Lorena Bresciani; Roberta Rossi; Cristina Testa; Cristina Geroldi; Samantha Galluzzi; Mikko P Laakso; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni
Journal:  Aging Clin Exp Res       Date:  2005-02       Impact factor: 3.636

3.  Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

Authors:  Darius Soonawala; Tania Amin; Klaus P Ebmeier; J Douglas Steele; Nadine J Dougall; Jonathan Best; Octave Migneco; Flavio Nobili; Klemens Scheidhauer
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

4.  Raven's coloured progressive matrices: normative values on 305 adult normal controls.

Authors:  A Basso; E Capitani; M Laiacona
Journal:  Funct Neurol       Date:  1987 Apr-Jun

5.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; D Carmelli
Journal:  Arch Neurol       Date:  2001-04

6.  Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Authors:  D Kogure; H Matsuda; T Ohnishi; T Asada; M Uno; T Kunihiro; S Nakano; M Takasaki
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

7.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

8.  Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Authors:  Nobuyuki Okamura; Hiroyuki Arai; Masahiro Maruyama; Makoto Higuchi; Toshifumi Matsui; Haruko Tanji; Takashi Seki; Hisao Hirai; Hiroshi Chiba; Masatoshi Itoh; Hidetada Sasaki
Journal:  Am J Psychiatry       Date:  2002-03       Impact factor: 18.112

9.  Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease.

Authors:  Yi-Chung Lee; Ren-Shyan Liu; Yi-Chu Liao; Chen-Ming Sun; Po-Shan Wang; Pei-Ning Wang; Hsiu-Chih Liu
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

10.  Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.

Authors:  A Newberg; A Cotter; M Udeshi; F Brinkman; G Glosser; A Alavi; C Clark
Journal:  Nucl Med Commun       Date:  2003-07       Impact factor: 1.690

View more
  17 in total

1.  Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.

Authors:  Lisa Mosconi
Journal:  Clin Transl Imaging       Date:  2013-08

2.  Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain.

Authors:  Huichun Xu; Boryana Stamova; Glen Jickling; Yingfang Tian; Xinhua Zhan; Bradley P Ander; Dazhi Liu; Renée Turner; Jonathan Rosand; Larry B Goldstein; Karen L Furie; Piero Verro; S Claiborne Johnston; Frank R Sharp; Charles S Decarli
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

3.  White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.

Authors:  Emily R Lindemer; David H Salat; Eric E Smith; Khoa Nguyen; Bruce Fischl; Douglas N Greve
Journal:  Neurobiol Aging       Date:  2015-05-28       Impact factor: 4.673

4.  Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.

Authors:  Alex E Roher; Suzanne L Tyas; Chera L Maarouf; Ian D Daugs; Tyler A Kokjohn; Mark R Emmerling; Zsolt Garami; Marek Belohlavek; Marwan N Sabbagh; Lucia I Sue; Thomas G Beach
Journal:  Alzheimers Dement       Date:  2011-03-09       Impact factor: 21.566

5.  Atrophy and lower regional perfusion of temporo-parietal brain areas are correlated with impairment in memory performances and increase of EEG upper alpha power in prodromal Alzheimer's disease.

Authors:  Vito Davide Moretti
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

6.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

7.  Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.

Authors:  Flavio Nobili; Giovanni B Frisoni; Florence Portet; Frans Verhey; Guido Rodriguez; Anna Caroli; Jacques Touchon; Piero Calvini; Silvia Morbelli; Fabrizio De Carli; Ugo P Guerra; Laura A Van de Pol; Pieter-Jelle Visser
Journal:  J Neurol       Date:  2008-08-01       Impact factor: 4.849

8.  Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.

Authors:  Annapaola Prestia; Anna Caroli; Karl Herholz; Eric Reiman; Kewei Chen; William J Jagust; Giovanni B Frisoni
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

Review 9.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

Review 10.  Mild Cognitive Impairment: Structural, Metabolical, and Neurophysiological Evidence of a Novel EEG Biomarker.

Authors:  Davide Vito Moretti
Journal:  Front Neurol       Date:  2015-07-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.